![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 47, 33279-33286, November 19, 1999
From the Department of Pharmacology and Physiology, University of
Medicine and Dentistry of New Jersey, The New Jersey Medical
School, Newark, New Jersey 07103
The effects of the protein phosphatase inhibitors
calyculin A and okadaic acid on Na+/Ca2+
exchange activity were examined in transfected Chinese hamster ovary
cells expressing the bovine cardiac Na+/Ca2+
exchanger. Incubating the cells for 5-10 min with 100 nM
calyculin A reduced exchange-mediated 45Ca2+
uptake or Ba2+ influx by 50-75%. Half-maximal inhibition
of 45Ca2+ uptake was observed at 15 nM calyculin A. The nonselective protein kinase inhibitors
K252a and staurosporine provided partial protection against the effects
of calyculin A. Okadaic acid, another protein phosphatase inhibitor,
nearly completely blocked exchange-mediated Ba2+ influx.
Chinese hamster ovary cells expressing a mutant exchanger in which 420 out of 520 amino acid residues were deleted from the central
hydrophilic domain of the exchanger remained sensitive to the
inhibitory effects of calyculin A and okadaic acid. Surprisingly, Nao+-dependent
Ca2+ efflux appeared to be only modestly inhibited, if at
all, by calyculin A or okadaic acid. We conclude that protein
hyperphosphorylation during protein phosphatase blockade selectively
inhibits the Ca2+ influx mode of
Na+/Ca2+ exchange, probably by an indirect
mechanism that does not involve phosphorylation of the exchanger itself.
The Na+/Ca2+ exchange system is the
primary Ca2+ efflux mechanism in cardiac myocytes and plays
a crucial role in regulating the cellular Ca2+ content and
the force of myocardial contraction (see reviews in Refs. 1-3). The
activity of the Na+/Ca2+ exchanger is regulated
by ATP- and Ca2+-dependent mechanisms. The
Ca2+-dependent process is thought to involve
the binding of Ca2+ to regulatory sites within the central
hydrophilic domain of the exchanger (4-6), but the mechanism
underlying the ATP-dependent regulatory process has been
less clearly defined. Investigations of exchange currents in excised
sarcolemmal patches indicate that the effects of ATP in this
experimental system are mediated by synthesis of phosphatidylinositol
4,5-bisphosphate (7, 8), rather than protein kinase activity (9).
On the other hand, evidence from several different laboratories
supports the view that the Na+/Ca2+ exchanger
is regulated by a phosphorylation-dephosphorylation process. The large
body of information favoring a phosphorylation mechanism in squid giant
axons has recently been reviewed (10). For the exchangers of vascular
smooth muscle and cardiac cells, direct evidence for phosphorylation of
the exchange protein and a modest stimulation of exchange activity
during protein kinase C activation have been reported (11, 12). Studies
with rat astrocytes, neurons, and the Xenopus expression
system suggest that protein kinase A stimulates the activity of certain
exchanger isoforms but not others (13). In contrast to the stimulation of exchange activity described in these studies, inhibition of exchange
activity was reported upon activation of protein kinases A and C in
bovine chromaffin cells (14) and human mesangial cells (15).
We had previously reported that ATP depletion partially inhibits
Na+/Ca2+ exchange activity in transfected
Chinese hamster ovary (CHO)1
cells expressing the bovine cardiac Na+/Ca2+
exchanger (16). A phosphorylation mechanism did not appear to be
involved, because inhibitors or activators of various protein kinases
did not affect Na+/Ca2+ exchange activity in
these cells, and phosphorylation of the immunoprecipitated exchange
protein was not detectable. As part of these studies, we reported that
okadaic acid and calyculin A, potent inhibitors of protein phosphatases
1 and 2A, had no effect on exchange-mediated
45Ca2+ fluxes when the inhibitors were added
directly to the assay medium. In the present report, we reinvestigated
the effects of these agents to determine whether exposing the cells to
the inhibitors for longer incubation periods would reveal an
acceleration of exchange activity through a
phosphorylation-dependent process. Instead, we found that
calyculin A and okadaic acid strongly inhibited the Ca2+
influx (reverse) mode of Na+/Ca2+ exchange.
Curiously, these treatments had little or no effect on the
Ca2+ efflux (forward) mode of exchange. The mechanism
involved is uncertain, but it does not appear to entail phosphorylation
of the exchanger itself.
Cells--
CHO cells expressing Na+/Ca2+
exchange activity (CK1.4 cells) were prepared by transfecting the cells
(CCL 61; American Type Culture Collection) with the expression vector
pcDNA I/Neo (Invitrogen Corp., Carlsbad, CA) containing a cDNA
insert coding for the bovine cardiac Na+/Ca2+
exchanger (17, 18). The cells were grown in Iscove's modified Dulbecco's medium containing 10% fetal calf serum and antibiotics as
described (18). CK138 cells were transfected with a deletion mutant of
the exchanger, Materials and Solutions--
Na-PSS contained 140 mM
NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM glucose, and 20 mM Mops, adjusted to pH 7.4 (37 °C) with Tris. K-PSS and NMDG-PSS had the same composition as
Na-PSS except that NaCl was replaced with KCl (total concentration, 140 mM) or NMDG. Na- and K-PSS were mixed to yield the
Na+ and K+ concentrations specified as 20/120,
28/112, or 40/100 Na/K-PSS. Fura-2-AM was purchased from Molecular
Probes, Inc. (Eugene, OR). Calyculin A and okadaic acid were from
Alexis Biochemicals (San Diego, CA). All other biochemicals were
purchased from Sigma.
45Ca2+ Uptake and Efflux
Assay--
These assays were conducted essentially as previously
described (16). Briefly, the culture medium was removed from cells grown in 24-well fibronectin-coated plastic dishes and replaced with 1 ml of nominally Ca2+-free Na-PSS containing 0.4 mM ouabain. For calyculin-treated cells, calyculin A (100 nM) was added to the preincubation medium after 20 min.
After 30 min of incubation at 37° C, the medium in each well was
replaced with 0.2 ml of 40/100 Na/K-PSS containing 1 mM
45CaCl2 (37 °C). After the desired interval,
the cells were washed four times with termination fluid consisting of
100 mM MgCl2 + 10 mM
LaCl3 + 5 mM Mops/Tris, pH 7.4. The
radioactivity was solubilized in 0.1 N HNO3,
counted in a scintillation counter, and normalized to the amount of
protein in the wells. For the 45Ca2+ efflux
assay, ouabain-treated cells were loaded with
45Ca2+ by reverse
Na+/Ca2+ exchange in 40/100 Na/K-PSS as
described above with or without 100 nM calyculin A present.
After the 10-min loading period, the medium was replaced with 1 ml of
either Na-PSS or NMDG-PSS, and the reaction was terminated after
various intervals as described above.
Fura-2-based Assays of Ba2+ Influx and
Ca2+ Efflux--
The Ba2+ influx assay for
Na+/Ca2+ exchange activity is fully described
in Ref. 21. Cells were grown to confluence in 75-cm2
culture flasks, washed three times with Na-PSS, and incubated for 1 min
at 37 °C with Na-PSS containing 5 mM EDTA to detach cells from the flask. The suspended cells were centrifuged at 700 × g for 1 min, resuspended in Na-PSS + 1 mM
CaCl2, centrifuged again, and resuspended in 4-5 ml of
Na-PSS + 1 mM CaCl2 containing 1% bovine serum
albumin. The cells were divided into 300-µl aliquots and incubated
for 30 min with 3 µM fura-2-AM and 0.25 mM
sulfinpyrazone (to retard transport of fura-2 out of the cells). The
fura-2 and sulfinpyrazone were added as 1000-fold concentrated stock
solutions in dimethyl sulfoxide.
After the 30-min loading period, the cells were centrifuged for several
seconds in an Eppendorf mini-centrifuge, washed, and preincubated for 5 min in 100 µl of Na-PSS + 1 mM CaCl2 or with other additions and conditions as indicated in individual experiments. These cells were then added directly to fluorescence cuvettes containing 3 ml of 20/120 Na/K-PSS + 0.3 mM EGTA.
Gramicidin (2 µg/ml) was added to the cuvettes to equilibrate
transmembrane Na+ and K+ gradients. After
monitoring fura-2 fluorescence for 30 s, 1 mM BaCl2 (30 µl of 0.1 M stock solution) was
added to the cuvette, and fura-2 fluorescence was monitored for an
additional 220 or 270 s, as indicated for individual experiments.
Fura-2 fluorescence was measured at 510 nm with alternate excitation at
350 and 390 nm using a Photon Technology International RF-M 2001 fluorometer (South Brunswick, NJ); data points were obtained at 1.8-s
intervals. All fluorescence values were corrected for autofluorescence
using cells that had not been loaded with fura-2. Data are presented as
the ratio of fluorescence for excitation at 350/390 nm and represent
the mean values (± S.E.; error bars shown in figures) for
the number of experiments (n) indicated in the figure legends.
To measure Ca2+ efflux activity, the cells were placed in
cuvettes containing either Na- or K-PSS + 0.3 mM EGTA.
Ca2+ release from internal stores was initiated by adding
ionomycin (0.6 µl; 10 mM in dimethyl sulfoxide), and
fura-2 fluorescence was monitored at the excitation wavelengths
appropriate for Ca2+ (340 and 380 nm). Dimethyl sulfoxide
alone at the concentrations used had no effect on Ca2+
release. The difference in the amplitude and duration of the ionomycin-induced [Ca2+]i transient in K-PSS
versus Na-PSS was taken as an indication of
exchange-mediated Ca2+ efflux activity (22, 23).
Calyculin A Inhibits Ca2+ Influx by
Na+/Ca2+ Exchange--
To measure
Na+/Ca2+ exchange activity, CK1.4 cells were
pretreated with ouabain for 30 min in Na-PSS to elevate the cytosolic Na+ concentration and then placed in a low
[Na+] medium (40/100 Na/K-PSS) containing 1 mM 45CaCl2. As shown in Fig.
1A,
45Ca2+ uptake was diminished by 55-75% when
the cells were treated with 50 nM calyculin A for the final
10 min of the preincubation period. A 5-10-min exposure to calyculin A
was necessary to elicit this inhibitory effect. As previously reported
(16), calyculin A did not inhibit 45Ca2+ uptake
when added to the assay medium without preincubation, and it had no
effect on 45Ca2+ uptake in cardiac sarcolemmal
vesicles (data not shown). Thus, calyculin A does not directly act on
the Na+/Ca2+ exchanger but presumably modulates
its activity through a phosphorylation-dependent mechanism.
The nonselective protein kinase inhibitor K252a (1 µM)
offered partial protection against the inhibitory effects of calyculin A when included in the preincubation medium (Fig. 1). In the absence of
calyculin, K252a had no effect on 45Ca2+ uptake
(data not shown). A related broad spectrum protein kinase inhibitor,
staurosporine (1 µM), also protected against inhibition by calyculin A (data not shown). Other protein kinase inhibitors were
tested but were found not to protect against the effects of calyculin.
These included 1 µM KN-62
(calmodulin-dependent protein kinase), 200 µM
genistein (tyrosine kinases), 0.5 µM calphostin C
(protein kinase C), 10 µM H-89 (protein kinase A), and
another relatively nonselective inhibitor, 50 µM H-7.
When calyculin-treated cells were subsequently incubated in a
calyculin-free medium for an additional 10 min, the rates of
45Ca2+ uptake continued to decline. Including
K252a in the calyculin-free medium enhanced recovery, but the rates of
45Ca2+ uptake remained less than 40% of
untreated controls (data not shown).
The Na+/Ca2+ exchange protein contains 11 transmembrane segments with a cytosolically disposed hydrophilic domain
of 520 amino acids residing between the 5th and 6th transmembrane
segments (1-3). The hydrophilic domain is thought to be essential for regulation of activity, because its elimination by chymotrypsin treatment or site-directed mutagenesis abrogates normal regulatory behavior (19). CHO cells expressing a mutant exchanger in which 440 residues from this domain have been deleted (CK138 cells) were treated
with calyculin A and assayed for 45Ca2+ uptake
by reverse Na+/Ca2+ exchange. As shown in Fig.
1B, calyculin A inhibited 45Ca2+
uptake by 40-65% in these cells. As with the CK1.4 cells, inhibition by calyculin A was partially alleviated by K252a. We conclude that the
effects of calyculin A are not mediated by phosphorylation of residues
within the deleted segment of this mutant. Although phosphorylation of
one or more of the residual serine or threonine residues remains a
possible mechanism for these effects, this seems implausible due to the
absence of normal regulatory behavior in this mutant.
The concentration dependence for inhibition of the initial rate of
45Ca2+ uptake by calyculin A is shown in Fig.
2. Maximal inhibition (64 ± 4%)
was observed at 100 nM, and the half-maximally effective concentration was approximately 15 nM. Longer incubation
periods with 100 nM calyculin did not increase the degree
of inhibition.
Exchange-mediated Ba2+
Uptake--
45Ca2+ entering the cells by
reverse Na+/Ca2+ exchange is accumulated by
intracellular organelles, especially mitochondria. Thus, the inhibition
of 45Ca2+ uptake observed with calyculin A
might have involved a reduction in organellar Ca2+
sequestration rather than an inhibition of
Na+/Ca2+ exchange activity. To examine this
possibility, we measured the exchange-mediated influx of
Ba2+ in fura-2-loaded cells treated with 2 µg/ml
gramicidin as described in Ref. 21. The presence of gramicidin, a
channel-forming monovalent cation ionophore, eliminates transmembrane
Na+ and K+ gradients and provides a continuous
supply of cytosolic Na+ for the activation of exchange
activity (21). As shown in Fig. 3,
treatment of CK1.4 cells or CK138 cells for 5 min with 100 nM calyculin A markedly inhibited the initial rate of
Ba2+ influx in both cell types. Because Ba2+ is
not accumulated by the endoplasmic reticulum in these cells and does
not appear to be extensively accumulated by mitochondria (21), we
conclude that the effects of calyculin A reflect the inhibition of
exchange activity itself rather than an impairment of organellar
Ca2+ sequestration.
The residual rate of Ba2+ influx in the calyculin-treated
CK138 cells was greater (p < 0.025) than for the
calyculin-treated CK1.4 cells (Fig. 3C). Moreover, the
degree of inhibition by calyculin A for the CK138 cells (44 ± 4.6%) was significantly less than for the CK1.4 cells (74 ± 2.4%; p < 10
When CK1.4 cells were treated with okadaic acid, a protein phosphatase
inhibitor with greater potency toward PP-2A than PP-1, we found that
exchange-mediated Ba2+ influx was nearly completely blocked
(87 ± 2.3% inhibition of initial rate) (Fig.
4, A and C).
Incubations of 60 min with okadaic acid were required to observe this
inhibition, consistent with a slow entry of this inhibitor into cells
(24, 25). Under identical conditions, okadaic acid methyl ester, an
inactive analog of okadaic acid, had no effect on Ba2+
influx (Fig. 4D). The okadaic acid treatment inhibited the
initial rate of Ba2+ influx in CK138 cells by 65 ± 3.4% (Fig. 4B). Although the percentage of inhibition was
less than for the CK1.4 cells, the rates of Ba2+ uptake
after okadaic acid treatment for both cell types were similar to those
seen for passive Ba2+ leakage into the cell in the absence
of exchange activity (21). Thus, the values given must be seen as lower
limits for the percentage of inhibition of exchange activity by okadaic
acid. Tautomycin (1 µM), a third protein phosphatase
inhibitor with reduced affinity for PP-2A compared with PP-1, had no
effect on Ba2+ influx after either a 5- or a 60-min
preincubation (Fig. 4D). The results suggest that the
effects of calyculin A and okadaic acid are mediated by blockade of
protein phosphatase 2A (see under "Discussion").
Other experiments demonstrated that K252a, as in the experiments with
calyculin A, partially protected against inhibition of Ba2+
influx by okadaic acid (data not shown). We were unable to mimic the
effects of the protein phosphatase inhibitors on Ba2+
influx by incubating the cells with phorbol 12-myristate 13-acetate (10 µM, 5 min), dibutyryl cAMP (1 mM, 5 or 60 min) or 8-bromo-cGMP (1 mM, 5 or 60 min).
To determine whether the inhibition of Ba2+ entry could be
overcome by increasing the cytosolic Na+ concentration, we
carried out the experiment shown in Fig.
5. CK1.4 cells were preincubated for 5 min with 2 µg/ml gramicidin in either Na-PSS or 28/112 Na/K-PSS, with
or without 100 nM calyculin A. Under these preincubation
conditions, the cytosol was loaded with either a high concentration
(~140 mM) or a low concentration (~28 mM)
of Na+ due to the presence of the monovalent cation
ionophore gramicidin; the Km for activation of
exchange activity by cytosolic Na+ is 18-28 mM
(19, 26). The cells were then diluted into K-PSS, and 1 mM
Ba2+ was added after 30 s. As expected, the cells with
high cytosolic Na+ (Fig. 5A) showed a greater
rate and extent of Ba2+ uptake than cells with low
cytosolic Na+ (Fig. 5B). Calyculin A treatment
inhibited the initial rates of Ba2+ influx by 57 ± 3.6 versus 68 ± 3.3% at 140 and 28 mM
Na+, respectively (Fig. 5C). The difference in
the two values (p < 0.05) is quite small and suggests
that calyculin A did not markedly affect the affinity of the exchanger
for Na+. In other experiments (data not shown),
Ba2+ influx was inhibited to the same extent by calyculin A
at Ba2+ concentrations of 1 mM and 5 mM; the Km for external Ba2+
uptake by Na+/Ca2+ exchange in these cells is 3 mM (21). The results indicate that calyculin A inhibition
is characterized by a reduction in the Vmax for
exchange activity, rather than changes in the affinity of the exchanger
for the transported ions.
Protein Phosphatase Inhibitors and Ca2+ Efflux--
We
expected the protein phosphatase inhibitors to reduce the
Ca2+ efflux mode of exchange activity to a similar extent
as for the Ca2+ influx mode. Surprisingly, this was not the
case. We adopted three different protocols to assess Ca2+
efflux mediated by Na+/Ca2+ exchange. In the
first approach, ouabain-treated CK1.4 cells were loaded with
45Ca2+ by a 10 min incubation in 40/100
Na/K-PSS containing 1 mM 45CaCl2,
with or without 100 nM calyculin A. The medium was then replaced with either NMDG-PSS or Na-PSS, and the rate of loss of
45Ca2+ from the cells was monitored. As shown
in Fig. 6, 45Ca2+
efflux was more rapid in Na-PSS than in NMDG-PSS, presumably reflecting
the acceleration of Ca2+ efflux by
Na+/Ca2+ exchange. Remarkably, calyculin A had
no effect on Na+-dependent
45Ca2+ efflux. In other experiments, the cells
were treated with calyculin A in Na-PSS for 10 min before beginning the
10 min 45Ca2+ loading period in 40/100
Na/K-PSS. Although the initial level of 45Ca2+
uptake was lower under these conditions than in Fig. 6, the results were essentially the same; i.e. the presence of
Na+ stimulated 45Ca2+ efflux,
indicating that exchange activity had not been blocked by the calyculin
A treatment (data not shown).
Another approach to measuring Ca2+ efflux was to assess the
effect of extracellular Na+ on the
[Ca2+]i transient elicited by the
Ca2+ ionophore ionomycin, which releases Ca2+
from intracellular stores. For the data shown in Fig.
7, A and B,
ionomycin (2 µM) was added to suspensions of CK1.4 cells
that had been preincubated for 5 min with or without 100 nM
calyculin A. The suspension medium was either Na-PSS + 0.3 mM EGTA or K-PSS + 0.3 mM EGTA, as indicated in
the figures. As shown for untreated cells in Fig. 7A, the
[Ca2+]i transient was reduced in amplitude and
shorter in duration in Na-PSS compared with K-PSS, a result that
reflects the activity of the Na+/Ca2+ exchanger
in mediating Ca2+ efflux (22, 23). Half-times for the
decline in [Ca2+]i from the peak value were 8.5 and 16 s in Na- and K-PSS, respectively, as determined from
first-order plots of the data (see legend to Fig. 7 for details.)
With calyculin-treated cells (Fig. 7B), the half-times were
13 and 26 s in Na- and K-PSS, respectively, indicating that
calyculin A prolonged the [Ca2+]i transient in
both Na- and K-PSS. The reasons for this behavior are not known. As
discussed in detail elsewhere (23), the time course of the
Ca2+ transient reflects a complex interplay between the
Ca2+ content of intracellular stores, rates of
Ca2+ efflux from the cell, and the time dependence of
Ca2+ release from internal stores, which occurs over
several tens of seconds in these cells. Calyculin treatment could have
affected any of these contributing processes. We assumed that the rate constant for the decline in [Ca2+]i in Na-PSS was
the sum of the Na-dependent component (due to
Na+/Ca2+ exchange) and the Na-independent
component, as measured in K-PSS. Subtracting the rate constants in
K-PSS from those obtained in Na-PSS (cf. legend to Fig. 7),
the Na+-dependent component was found to be
reduced by 37% in the calyculin-treated cells. Although this value
suggests that exchange activity may have been inhibited by the
calyculin A treatment, the results with okadaic acid do not support
such a conclusion, as discussed below.
The ionomycin-induced [Ca2+]i transients for
untreated cells and cells incubated for 60 min with 1 µM
okadaic acid are shown in Fig. 7, C and D. The
half-times for the decline in [Ca2+]i in
untreated cells (Fig. 7C) were 14 and 18 s in Na- and
K-PSS, respectively. With the batch of cells used for this experiment,
the effect of Na+ was somewhat reduced compared with the
results described for the cells in Fig. 7A. For cells
treated with okadaic acid (Fig. 7D), the corresponding
half-times were 26 and 46 s. In this case, the
Na+-dependent component was not reduced but
increased by 16% following the okadaic acid treatment,
suggesting that there was no impairment of exchange activity.
This analysis must be viewed cautiously because the
Na-dependent component of the decline in
[Ca2+]i provides only a rough estimate of
exchange activity. As discussed elsewhere (23), ionomycin-induced
Ca2+ release is not instantaneous in these cells but
appears to continue at a declining rate over several tens of seconds.
Thus, the duration of the [Ca2+]i transient will
be determined to a significant degree by the underlying rate of
Ca2+ release. Both calyculin A and okadaic acid induce
major cytoskeletal alterations (cf. "Discussion"), which
could influence the quantity of stored Ca2+ and/or the rate
of Ca2+ release. These factors make it difficult to
quantitate exchange activity with certainty in these experiments.
Nevertheless, the results clearly indicate that the exchanger remains
capable of carrying out Ca2+ efflux following treatment
with the phosphatase inhibitors. The results with okadaic acid are
especially noteworthy because this agent almost completely abrogated
exchange-mediated Ba2+ influx (cf. Fig. 4) but
did not appear to markedly impair Ca2+ efflux.
A final index of exchange-mediated Ca2+ efflux is shown in
Fig. 8. In this experiment, CK1.4 cells
were pretreated for 10 min, with or without 100 nM
calyculin A, in the presence of ionomycin to deplete internal stores.
The cells were then added to cuvettes containing either Na-PSS or K-PSS
(final ionomycin concentration, 1.3 µM), and the rate of
Ca2+ entry upon addition of 1 mM
CaCl2 was monitored. In these experiments, Ca2+
entry occurs both through the ionophoretic behavior of ionomycin and
through store-dependent Ca2+ entry channels.
For the CK1.4 cells in K-PSS, reverse Na+/Ca2+
exchange also contributes to Ca2+ entry (22). As shown in
Fig. 8, the initial rate of Ca2+ influx was reduced by
30 ± 9% in Na-PSS (Fig. 8D), whereas the amplitude of
the rise in [Ca2+]i was reduced by 53 ± 6%
(Fig. 8A). The reduced rise in [Ca2+]i
in Na-PSS reflects the effect of Na+ in inhibiting
Ca2+ influx and promoting Ca2+ efflux via the
exchanger (22). This interpretation is supported by the data for
vector-transfected control cells, which do not express an endogenous
Na+/Ca2+ exchanger; for these cells, both the
rate (Fig. 8D) and the extent (Fig. 8C) of the
rise in [Ca2+]i were identical in Na-PSS and
K-PSS.
With calyculin-treated CK1.4 cells (Fig. 8, B and
D), the rate of Ca2+ entry in K-PSS was reduced
by 42 ± 8% compared with untreated cells, probably because
calyculin A-treatment inhibits both store-dependent Ca2+ entry (see under "Discussion") and reverse
Na+/Ca2+ exchange. In Na-PSS, the initial rate
of Ca2+ influx (Fig. 8D) was reduced by 62 ± 6% in Na-PSS compared with K-PSS, whereas the amplitude of the rise
in [Ca2+]i was reduced by 59 ± 4% (Fig.
8B). Note that the effect of Na+ on the initial
rate of Ca2+ entry was proportionally greater for the
calyculin-treated cells (62% inhibition) than for the untreated cells
(30% inhibition) (p < 0.001) (Fig. 8D). If
we assume that the differences between the initial rates of
Ca2+ influx in K-PSS and Na-PSS were entirely due to
Ca2+ efflux by the exchanger, the results would indicate
that the rate of
Nao+-dependent
Ca2+ efflux had increased by 21 ± 15% in the
calyculin-treated cells. We conclude that the calyculin A treatment did
not inhibit exchange-mediated Ca2+ efflux in these experiments.
For the vector-transfected control cells, calyculin A treatment
inhibited the initial rate of Ca2+ entry by 66 ± 9%
(Fig. 8, C and D), probably due to inhibition of
store-dependent Ca2+ entry (see under
"Discussion"). The reasons for the greater inhibition of
Ca2+ entry by calyculin A in control cells compared with
CK1.4 cells are not known. In any event, the rates of Ca2+
entry in Na- and K-PSS were essentially identical in the
calyculin-treated control cells, indicating that the effects
of Na+ seen in the CK1.4 cells were indeed due to
Na+/Ca2+ exchange activity.
Calyculin A is a potent inhibitor of PP-1 and PP-2A, with
Ki values of 1 and 0.12 nM,
respectively, as determined from recent binding and dose inhibition
measurements (25). Okadaic acid exhibits Ki values
of 0.032 nM for PP-2A and 147 nM for PP-1 (25).
In intact cells, phosphatase inhibitors must be applied at
concentrations much higher than their Ki values to
be effective, presumably because of poor entry into the cells. Thus, in
a recent study with MCF7 cells, Favre et al. (27) reported
that 100 nM calyculin A inhibited both PP-1 and PP-2A
activity by 60-70% within 20 min, the earliest time point examined; a
lower concentration of calyculin A (10 nM) required nearly
2 h of incubation to produce the same degree of inhibition. Longer
incubations of intact cells with 100 nM calyculin A did not
produce more than 70% inhibition of either phosphatase, although 100%
inhibition could be observed in cell-free extracts. In the same study,
okadaic acid (1 µM) inhibited nearly 100% of the PP-2A activity within 60 min but did not inhibit PP-1 activity at all during
a 3-h incubation period. Thus, the response of protein phosphatases to
inhibitors in intact cells is often slow and incomplete, and this
behavior complicates the interpretation of results.
In the present study, calyculin A inhibited "reverse-mode" exchange
activity by 60-75% after incubation periods of 5-10 min, and okadaic
acid inhibited Ba2+ influx by nearly 100% after incubation
periods of 60 min. The relative effectiveness of calyculin A and
okadaic acid is similar to that reported by Favre et al.
(27) for PP-2A inhibition, and we therefore suggest that the effects of
these inhibitors are probably mediated by blockade of PP-2A. We also
tested tautomycin (1 µM), which has a reduced affinity
for PP-2A (30 nM) compared with PP-1 (0.5 nM)
(25), and did not observe inhibition of exchange activity (Fig.
4C). The significance of this finding is uncertain, however,
because different cell types vary greatly in their response to
tautomycin. In the experiments of Favre et al. (27), for example, exposure to 10 µM tautomycin for more than
2 h was required for 50% inhibition of PP-1 activity. On the
other hand, studies in our laboratory with L6 cells revealed
significant effects of 1 µM tautomycin within 5-10 min
of incubation.2
The effects of the phosphatase inhibitors probably result from
hyperphosphorylation of cellular proteins, because protein kinase
inhibitors such as K252a (Fig. 1) and staurosporine partially protected
against the effects of calyculin A and okadaic acid. More selective
inhibitors of protein kinase A, protein kinase C, or
calmodulin-dependent protein kinase did not influence the effects of calyculin A. Moreover, we were unable to mimic the effects
of the protein phosphatase inhibitors by incubating the cells with
agents known to activate protein kinases A, C, and G. Thus, the protein
kinase(s) responsible for the phosphorylation-dependent inhibition of exchange activity remain unidentified.
Direct phosphorylation of the exchanger itself is probably not involved
in these effects, although this possibility cannot be completely
eliminated. Previously published immunoprecipitation experiments with
32P-labeled CK1.4 cells failed to disclose detectable
amounts of phosphorylated exchanger, even in calyculin-treated cells
(16). (Exchanger phosphorylation has been detected in other cell types, however (11, 12).) Moreover, cells expressing a deletion mutant (CK138
cells), which is missing much of the central hydrophilic domain of the
exchanger, remained susceptible to the effects of protein phosphatase
blockade (Figs. 1, 3, and 4). Many residual serines and threonines
remain in this mutant, including a potential casein kinase 2 phosphorylation site at 720-SAGEDDDD. However, it is unlikely that the
deletion mutant could mediate a regulatory response to putative
phosphorylation, because previous studies have demonstrated that all
well characterized modes of exchanger regulation are absent in this
mutant (19). Calyculin A and okadaic acid were somewhat less effective
in blocking Ba2+ influx in the mutant than the wild-type
exchanger (Figs. 1 and 3). These results suggest that the hydrophilic
domain mediates a portion of the inhibitory effect of these agents on
exchange activity. Although it is possible, but unlikely, that this
portion of the response is due to exchanger phosphorylation, other
aspects of exchanger function mediated by the hydrophilic domain,
e.g. possible interactions with cytoskeletal proteins (16),
could equally well be involved.
It is remarkable that exchange-mediated Ca2+ efflux
activity appeared to be resistant to the effects of protein phosphatase blockade (Figs. 6-8).
Nao+-dependent
45Ca2+ efflux was unaffected by calyculin A
treatment (Fig. 6). Na+ also remained effective in
attenuating the ionomycin-induced increase in
[Ca2+]i in cells treated with calyculin A or
okadaic acid (Fig. 7). Although the results with calyculin A were
consistent with partial inhibition of exchange-mediated
Ca2+ efflux, the results with okadaic acid were not. The
okadaic acid data are particularly noteworthy because this agent
blocked exchange-mediated Ba2+ influx nearly completely
(Fig. 4, A and C). Finally, the presence of
extracellular Na+ blunted the rise in
[Ca2+]i produced by the addition of extracellular
Ca2+ in ionomycin-treated CK1.4 cells, whether or not the
cells had been pretreated with calyculin A (Fig. 8). The results of
each of these approaches are consistent with the conclusion that the protein phosphatase blockade did not inhibit exchange activity operating in the Ca2+ efflux mode.
The selective inhibition of the reverse mode of exchange activity did
not appear to involve changes in the affinity for the transported ions,
or alterations in normal regulatory behavior. Thus, the inhibition by
calyculin A was nearly the same at concentrations of cytosolic
Na+ (Fig. 5) or external Ba2+ (data not shown)
that were above the Km value compared to
concentrations at or below the Km value. Moreover, the CK138 cells, which express an unregulated exchanger (19), remain
susceptible to inhibition by protein phosphatase blockade, albeit with
reduced sensitivity compared with the CK1.4 cells (Figs. 1, 3, and 4).
Thus, an explanation for the results in terms of the conventional
regulatory or kinetic properties of the exchanger remains elusive.
Recently, the novel exchange antagonist KB-R7943 was shown to be
considerably more potent in inhibiting the reverse, Ca2+
influx mode of exchange activity than the Ca2+ efflux mode
(28, 29). The mechanism underlying this differential inhibition of
activity has not yet been clarified. Perhaps there is an intrinsic
difference in susceptibility of the two modes of exchange activity to
inhibitors or other modulatory agents. The situation might be analogous
to Nai-dependent inactivation (30, 31), in
which exchange carriers enter an inactive state when they interact with
high concentrations of Na+ at the cytosolic membrane
surface. It is possible that in this configuration, the exchanger is
preferentially sensitive to inhibition by phosphatase blockade or the
presence of KB-R7943. This property could be an important factor in
protecting cells against Ca2+ overload during periods of
ischemia, when the cystosolic Na+ concentration rises to
levels that would bring about net Ca2+ influx by
reverse Na+/Ca2+ exchange.
Dramatic cytoskeletal changes occur in many cells upon inhibition of
protein phosphatase activity (32-35). These cytoskeletal changes might
influence exchanger location or its interactions with associated
proteins, thereby inhibiting its activity. Preliminary microscopic
observations using fluorescently labeled probes or antibodies have
verified that CK1.4 cells exposed to calyculin A exhibit extensive
disruption of intermediate filaments, microtubules and stress fibers
(data not shown). The relationship, if any, between these cytoskeletal
alterations and exchange activity is unclear. Treatment of CK1.4 cells
with nocodazole and/or cytochalasin D, agents that disrupt microtubules
and F-actin filaments, respectively, did not inhibit exchange activity
in preliminary experiments (data not shown). Disruption of the
intermediate filament system could conceivably affect exchange
activity, because the cytoskeletal protein ankyrin interacts with both
intermediate filaments (36, 37) and the
Na+/Ca2+ exchanger (38). This suggestion is
entirely speculative, however. Protein phosphatase inhibitors often
cause extensive vacuolization and membrane internalization (39, 40),
and this process could lead to loss of exchanger protein from the
external membrane surface. However, this possibility is difficult to
reconcile with the Ca2+ efflux results, which suggest
little or no impairment of exchanger function. Moreover, wholesale
internalization of plasma membrane transporters seems unlikely because
calyculin A treatment did not inhibit Na+/H+
exchange or bumetanide-sensitive 86Rb+ uptake
activities (data not shown). At present, therefore, it is uncertain
whether the extensive cytoskeletal alterations produced during protein
phosphatase blockade are an important factor in the inhibition of
exchange activity.
A final consideration involves the effects of the protein phosphatase
inhibitors on other Ca2+ influx mechanisms. Calyculin A and
okadaic acid strongly inhibit store-dependent
Ca2+ entry in several different cell types (41-45),
although there have also been reports that okadaic acid stimulates
store-dependent Ca2+ entry under some
conditions (46, 47). We have found that calyculin A reduces
store-dependent entry of Ca2+,
Ba2+, and Mn2+ in CHO
cells.3 We have also found
that calyculin A and okadaic acid treatments block Ba2+
entry through L-type Ca2+ channels in the L6
rat skeletal muscle cell line.2 These findings raise the
possibility that protein phosphatase blockade elicits a general
inhibition of divalent cation entry, perhaps involving cytoskeletal
changes as a common mechanistic element. Studies examining this
possibility are currently in progress.
In summary, the results have revealed a profound inhibition of the
Ca2+ influx mode of Na+/Ca2+
exchange activity during protein phosphatase blockade. Surprisingly, the Ca2+ efflux mode of exchange activity appeared to be
relatively unaffected. The mechanism involved is unclear, but it
probably does not involve phosphorylation of the exchanger itself. The
selective inhibition of Ca2+ influx could involve an
instrinsic difference in the susceptibility of the two modes of
exchange activity to protein hyperphosphorylation or to cytoskeletal
changes, or possibly a more general mechanism that suppresses divalent
cation entry.
*
This work was supported by National Institutes of Health
Grant HL49932.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Recipient of a predoctoral fellowship from the American Heart
Association, New Jersey Affiliate.
¶
To whom correspondence should be addressed: Dept. of
Pharmacology & Physiology, UMDNJ-NJ Medical School, 185 S. Orange
Ave., Newark, NJ 07103. Tel.: 973-972-3890; Fax: 973-972-7950; E-mail: reeves@umdnj.edu.
2
B. M. Hantash, unpublished observations.
3
M. Condrescu, B. M. Hantash, Y. Fang, and
J. P. Reeves, unpublished observations.
The abbreviations used are:
CHO, Chinese hamster
ovary;
NMDG, N-methyl-D-glucamine;
PP, protein
phosphatase;
PSS, physiological salts solution;
Mops, 3-(N-morpholino)propanesulfonic acid.
Mode-specific Inhibition of Sodium-Calcium Exchange during
Protein Phosphatase Blockade*
,
§,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(241-680), missing 440 out of the 520 amino acids of
the central hydrophilic domain of the exchanger, as described (16). The
kinetic and regulatory behavior of this mutant in excised patches (19)
and in the transfected CHO cells (16, 20) has been described previously.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (20K):
[in a new window]
Fig. 1.
Inhibition of exchange-mediated
45Ca2+ uptake by calyculin A. A, CK1.4 cells were pretreated with ouabain (30 min) and
then assayed for 45Ca2+ uptake as described
under "Experimental Procedures" (control,
n = 10). For the other traces, 50 nM
calyculin A (CA, n = 5) or 50 nM
calyculin A plus 1 µM K252a (CA + K252a,
n = 2) was included during the last 10 min of the
preincubation period. B, CK138 cells were treated as
described in A for the CK1.4 cells (n = 4 for each trace).

View larger version (13K):
[in a new window]
Fig. 2.
Concentration dependence of inhibition of
45Ca2+ uptake by calyculin A. CK1.4 cells
were pretreated with ouabain for 30 min. The indicated concentrations
of calyculin A were added to the medium for the final 10 min of the
preincubation period. The cells were then assayed for
45Ca2+ uptake (15 s) in 40/100 Na/K-PSS as
described under "Experimental Procedures" (n = 5-6). The results are expressed as the percentage of
45Ca2+ uptake for calyculin-free
controls.

View larger version (20K):
[in a new window]
Fig. 3.
Effect of calyculin A on Ba2+
influx in CK1.4 (A) and CK138 (B)
cells. Cells were loaded with fura-2 and assayed for
Ba2+ influx in 20/120 Na/K-PSS containing 2 µg/ml
gramicidin (see under "Experimental Procedures"). Prior to the
assay, the cells were preincubated for 5 min in Na-PSS + 1 mM CaCl2 with (CA) or without 100 nM calyculin A. C, initial rates of
Ba2+ influx were measured as the slopes of the individual
traces over the interval 88-120 s (n = 6-9).
5). Thus, the effects of
calyculin A are less pronounced for the mutant than for the wild-type
exchanger. A similar pattern was evident in the
45Ca2+ uptake studies (Fig. 1). We conclude
that the hydrophilic domain of the exchanger mediates a portion of the
inhibitory effects of protein phosphatase blockade but that substantial
inhibition was still observed even in the absence of most of the
hydrophilic domain.

View larger version (32K):
[in a new window]
Fig. 4.
Effect of okadaic acid on Ba2+
influx in CK1.4 (A) and CK138 (B)
cells. Experiments were conducted as described in the legend to
Fig. 3, except that the cells were preincubated with 1 µM
okadaic acid for 60 min prior to the assay; the cells were loaded with
fura-2 during the final 30 min of the preincubation period.
C, rates of Ba2+ influx were analyzed between 35 and 65 s. For CK1.4 cells, n = 6; for the CK138
cells, n = 7-9. D, rates of
Ba2+ influx, expressed as a percentage of untreated
controls, for cells preincubated 60 min with 1 µM okadaic
acid methyl ester (O-Me, n = 4) or for 5 min
(T-5', n = 3) or 60 min (T-60',
n = 5) with 1 µM tautomycin.

View larger version (17K):
[in a new window]
Fig. 5.
Ba2+ uptake by CK1.4 cells loaded
with high or low cytosolic Na+ concentrations: effect of
calyculin A treatment. Aliquots of fura-2 loaded cells were
preincubated for 5 min in either Na-PSS (A) or 28/112
Na/K-PSS (B) containing 0.3 mM EGTA, 2 µg/ml
gramidicin, and 10 µM ionomycin, with (CA) or
without (Cont.) 100 nM calyculin A. The cells
were diluted 30-fold into fluorescence cuvettes containing K-PSS + 0.3 mM EGTA, and 1 mM BaCl2 was added
as indicated. C, rates of Ba2+ influx, computed
from the slope of the fura-2 traces 4-18 s following the addition of
Ba2+. Ionomycin was used to deplete internal
Ca2+ stores in these experiments; as discussed elsewhere
(21), ionomycin does not act as an ionophore toward Ba2+
(n = 5-6).

View larger version (18K):
[in a new window]
Fig. 6.
45Ca2+ efflux from
CK1.4 cells: effects of calyculin A. Cells were assayed for
45Ca2+ efflux in Na- or NMDG-PSS as described
under "Experimental Procedures." For calyculin-treated cells
(filled symbols), 100 nM calyculin A was
included in the medium during the 10-min 45Ca2+
uptake period (n = 5-6).

View larger version (29K):
[in a new window]
Fig. 7.
Ionomycin-induced Ca2+ release in
Na- or K-PSS following treatment with either calyculin A or okadaic
acid. Fura-2-loaded CK1.4 cells were preincubated in Na-PSS + 1 mM CaCl2 for 5 min with (B) or
without (A) 100 nM calyculin A
(n = 6). In separate experiments with a different batch
of CK1.4 cells, cells were preincbuated for 60 min with (D)
or without (C) 1 µM okadaic acid
(n = 5). The cells were added to fluorescence cuvettes
containing 3 ml of Na- or K-PSS as indicated; ionomycin (2 µM) was added to initiate Ca2+ release from
internal stores at 30 s (arrow). See text for further
details. First order plots were constructed for the decline in
[Ca2+]i from the peak of the transient (not
shown), and the slopes of the initial portions of these plots yielded
the following rate constants for the data in Na- and K-PSS,
respectively: A, 0.0818 and 0.0423 s
1;
B, 0.0517 and 0.0268 s
1; C,
0.0491and 0.0390 s
1; D, 0.0269 and 0.0151 s
1.

View larger version (33K):
[in a new window]
Fig. 8.
Ca2+ influx in CK1.4 cells or
vector-transfected control cells in Na- or K-PSS; effect of calyculin A
treatment. A, aliquots of fura-2-loaded CK1.4 cells
were preincubated for 1 min with 10 µM ionomycin in
Na-PSS + 0.3 mM EGTA and diluted 30-fold into fluorescence
cuvettes containing Na- or K-PSS, as indicated, plus 0.3 mM
EGTA and additional (1 µM) ionomycin. CaCl2
(1 mM) was added at 30 s (arrow).
B, CK1.4 cells were treated as in A, except that
100 nM calyculin A was included during the final 10 min of
the fura-2 loading period. C, vector-transfected CHO cells
were treated with or without calyculin A as described for the CK1.4
cells. The data in Na-PSS are indicated by the boldface
traces in C; the lighter traces are for data
in K-PSS. S.E. bars are omitted in C for clarity.
For the CK1.4 cells, n = 4-5; for the control cells,
n = 3.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
FOOTNOTES
These authors contributed equally to this work.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Hryshko, L. V.,
and Philipson, K. D.
(1997)
Basic. Res. Cardiol.
92 Suppl. 1,
45-51
2.
Reeves, J. P.
(1998)
J. Bioenerg. Biomembr.
30,
151-160[CrossRef][Medline]
[Order article via Infotrieve]
3.
Blaustein, M. P.,
and Lederer, W. J.
(1999)
Physiol. Rev.
79,
763-854 4.
Matsuoka, S.,
Nicoll, D. A.,
Hryshko, L. V.,
Levitsky, D. O.,
Weiss, J. N.,
and Philipson, K. D.
(1995)
J. Gen. Physiol.
105,
403-420 5.
Levitsky, D. O.,
Nicoll, D. A.,
and Philipson, K. D.
(1994)
J. Biol. Chem.
269,
22847-22852 6.
DiPolo, R.
(1979)
J. Gen. Physiol.
73,
91-113 7.
Hilgemann, D. W.,
and Ball, R.
(1996)
Science
273,
956-959[Abstract]
8.
Hilgemann, D. W.
(1997)
Annu. Rev. Physiol.
59,
193-220[CrossRef][Medline]
[Order article via Infotrieve]
9.
Collins, A.,
Somlyo, A. V.,
and Hilgemann, D. W.
(1992)
J. Physiol.
454,
27-57 10.
DiPolo, R.,
and Beaugé, L.
(1999)
Biochim. Biophys. Acta
1422,
57-71[Medline]
[Order article via Infotrieve]
11.
Iwamoto, T.,
Pan, Y.,
Wakabayashi, S.,
Imagawa, T.,
Yamanaka, H. I.,
and Shigekawa, M.
(1996)
J. Biol. Chem.
271,
13609-13615 12.
Shigekawa, M.,
Iwamoto, T.,
and Wakabayashi, S.
(1996)
Ann. N. Y. Acad. Sci.
779,
249-257[Medline]
[Order article via Infotrieve]
13.
He, S.,
Ruknudin, A.,
Bambrick, L. L.,
Lederer, W. J.,
and Schulze, D. H.
(1998)
J. Neurosci.
18,
4833-4841 14.
Lin, L. F.,
Kao, L. S.,
and Westhead, E. W.
(1994)
J. Neurochem.
63,
1941-1947[Medline]
[Order article via Infotrieve]
15.
Mene, P.,
Pugliese, F.,
and Cinotti, G. A.
(1993)
Exp. Nephrol.
1,
245-252[Medline]
[Order article via Infotrieve]
16.
Condrescu, M.,
Gardner, J. P.,
Chernaya, G.,
Aceto, J. F.,
Kroupis, C.,
and Reeves, J. P.
(1995)
J. Biol. Chem.
270,
9137-9146 17.
Aceto, J. F.,
Condrescu, M.,
Kroupis, C.,
Nelson, H.,
Nelson, N.,
Nicoll, D.,
Philipson, K. D.,
and Reeves, J. P.
(1992)
Arch. Biochem. Biophys.
298,
553-560[CrossRef][Medline]
[Order article via Infotrieve]
18.
Pijuan, V.,
Zhuang, Y.,
Smith, L.,
Kroupis, C.,
Condrescu, M.,
Aceto, J. F.,
Reeves, J. P.,
and Smith, J. B.
(1993)
Am. J. Physiol.
264,
C1066-C1074 19.
Matsuoka, S.,
Nicoll, D. A.,
Reilly, R. F.,
Hilgemann, D. W.,
and Philipson, K. D.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
3870-3874 20.
Fang, Y.,
Condrescu, M.,
and Reeves, J. P.
(1998)
Am. J. Physiol.
275,
C50-C55
21.
Condrescu, M.,
Chernaya, G.,
Kalaria, V.,
and Reeves, J. P.
(1997)
J. Gen. Physiol.
109,
41-51 22.
Chernaya, G.,
Vazquez, M.,
and Reeves, J. P.
(1996)
J. Biol. Chem.
271,
5378-5385 23.
Fang, Y., Condrescu, M., and Reeves, J. P. (1999) Cell
Calcium, in press
24.
Wera, S.,
and Hemmings, B. A.
(1995)
Biochem. J.
311,
17-29
25.
Takai, A.,
Sasaki, K.,
Nagai, H.,
Mieskes, G.,
Isobe, M.,
Isono, K.,
and Yasumoto, T.
(1995)
Biochem. J.
306,
657-665
26.
Matsuoka, S.,
Nicoll, D. A.,
He, Z.,
and Philipson, K. D.
(1997)
J. Gen. Physiol.
109,
273-286 27.
Favre, B.,
Turowski, P.,
and Hemmings, B. A.
(1997)
J. Biol. Chem.
272,
13856-13863 28.
Iwamoto, T.,
Watano, T.,
and Shigekawa, M.
(1996)
J. Biol. Chem.
271,
22391-22397 29.
Watano, T.,
Kimura, J.,
Morita, T.,
and Nakanishi, H.
(1996)
Br. J. Pharmacol.
119,
555-563[Medline]
[Order article via Infotrieve]
30.
Hilgemann, D. W.
(1996)
Biophys. J.
71,
759-768 31.
Hilgemann, D. W.,
Matsuoka, S.,
Nagel, G. A.,
and Collins, A.
(1992)
J. Gen. Physiol.
100,
905-932 32.
Yano, Y.,
Sakon, M.,
Kambayashi, J.,
Kawasaki, T.,
Senda, T.,
Tanaka, K.,
Yamada, F.,
and Shibata, N.
(1995)
Biochem. J.
307,
439-449
33.
Maier, G. D.,
Wright, M. A.,
Lozano, Y.,
Djordjevic, A.,
Matthews, J. P.,
and Young, M. R.
(1995)
Int. J. Cancer
61,
54-61[Medline]
[Order article via Infotrieve]
34.
Almazan, G.,
Afar, D. E.,
and Bell, J. C.
(1993)
J. Neurosci. Res.
36,
163-172[CrossRef][Medline]
[Order article via Infotrieve]
35.
Hirano, K.,
Chartier, L.,
Taylor, R. G.,
Allen, R. E.,
Fusetani, N.,
Karaki, H.,
and Hartshorne, D. J.
(1992)
J. Muscle Res. Cell Motil.
13,
341-353[CrossRef][Medline]
[Order article via Infotrieve]
36.
Georgatos, S. D.,
and Marchesi, V. T.
(1985)
J. Cell Biol.
100,
1955-1961 37.
Georgatos, S. D.,
and Maison, C.
(1996)
Int. Rev. Cytol.
164,
91-138[Medline]
[Order article via Infotrieve]
38.
Li, Z. P.,
Burke, E. P.,
Frank, J. S.,
Bennett, V.,
and Philipson, K. D.
(1993)
J. Biol. Chem.
268,
11489-11491 39.
Boe, R.,
Gjertsen, B. T.,
Vintermyr, O. K.,
Houge, G.,
Lanotte, M.,
and Doskeland, S. O.
(1991)
Exp. Cell Res.
195,
237-246[CrossRef][Medline]
[Order article via Infotrieve]
40.
Takuma, T.,
Ichida, T.,
Okumura, K.,
and Kanazawa, M.
(1993)
FEBS Lett.
323,
145-150[CrossRef][Medline]
[Order article via Infotrieve]
41.
Marriott, I.,
and Mason, M. J.
(1996)
J. Biol. Chem.
271,
26732-26738 42.
Tojyo, Y.,
Tanimura, A.,
and Matsumoto, Y.
(1995)
Jpn. J. Pharmacol.
69,
381-389[Medline]
[Order article via Infotrieve]
43.
Sakai, T.,
and Ambudkar, I. S.
(1996)
Am. J. Physiol.
271,
C284-C294 44.
Koike, Y.,
Ozaki, Y.,
Qi, R.,
Satoh, K.,
Kurota, K.,
Yatomi, Y.,
and Kume, S.
(1994)
Cell Calcium
15,
381-390[CrossRef][Medline]
[Order article via Infotrieve]
45.
Berlin, R. D.,
and Preston, S. F.
(1993)
Cell Calcium
14,
379-386[CrossRef][Medline]
[Order article via Infotrieve]
46.
Parekh, A. B.,
Terlau, H.,
and Stuhmer, W.
(1993)
Nature
364,
814-818[CrossRef][Medline]
[Order article via Infotrieve]
47.
Randriamampita, C.,
and Tsien, R. Y.
(1995)
J. Biol. Chem.
270,
29-32
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Katanosaka, Y. Iwata, Y. Kobayashi, F. Shibasaki, S. Wakabayashi, and M. Shigekawa Calcineurin Inhibits Na+/Ca2+ Exchange in Phenylephrine-treated Hypertrophic Cardiomyocytes J. Biol. Chem., February 18, 2005; 280(7): 5764 - 5772. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Fernandez, M.-H. Huang, B. A. Davidson, P. R Knight III, and J. L. Izzo Jr Mechanisms of Angiotensin II-Mediated Decreases in Intraneuronal Ca2+ in Calcium-Loaded Stellate Ganglion Neurons Hypertension, February 1, 2005; 45(2): 276 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shigekawa and T. Iwamoto Cardiac Na+-Ca2+ Exchange : Molecular and Pharmacological Aspects Circ. Res., |